We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.92B
AUM Growth
-$861M
Cap. Flow
-$1.08B
Cap. Flow %
-56.34%
Top 10 Hldgs %
24.9%
Holding
1,961
New
419
Increased
272
Reduced
381
Closed
669

Sector Composition

Rank Sector Weight
1 Financials 17.05%
2 Technology 12.34%
3 Consumer Discretionary 8.56%
4 Industrials 7.99%
5 Healthcare 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPAC
1751
DELISTED
Bullpen Parlay Acquisition Company Class A Ordinary Share
BPAC
-50,000
Closed -$504K
TCRR
1752
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-16,715
Closed -$30K
STET.WS
1753
DELISTED
ST Energy Transition I Ltd. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50, included as part of the SAIL securities
STET.WS
-25,000
Closed -$2K
FOXO.WS
1754
DELISTED
FOXO Technologies Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FOXO.WS
-20,044
Closed -$2K
PGRWW
1755
DELISTED
Progress Acquisition Corp. Warrant
PGRWW
-21,106
Closed -$2K
SVNA
1756
DELISTED
7 Acquisition Corp
SVNA
-31,130
Closed -$315K
EVOJW
1757
DELISTED
Evo Acquisition Corp. Warrant
EVOJW
-27,526
Closed -$1K
ADALW
1758
DELISTED
Anthemis Digital Acquisitions I Corp Warrant
ADALW
-31,327
Closed -$4K
TRAQ
1759
DELISTED
Trine II Acquisition Corp.
TRAQ
-121,200
Closed -$1.22M
BMAQW
1760
DELISTED
Blockchain Moon Acquisition Corp. Warrants
BMAQW
-27,000
Closed -$1K
KALWW
1761
DELISTED
Kalera Public Limited Company Warrant
KALWW
-95,045
Closed -$11K
REVEW
1762
DELISTED
Alpine Acquisition Corp Warrant
REVEW
-15,000
Closed -$2K
SMIHW
1763
DELISTED
Summit Healthcare Acquisition Corp. Warrant
SMIHW
-29,187
Closed -$4K
AGGR
1764
DELISTED
Agile Growth Corp
AGGR
-20,000
Closed -$198K
ESM.WS
1765
DELISTED
ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ESM.WS
-10,597
Closed -$1K
ESM
1766
DELISTED
ESM Acquisition Corporation
ESM
-25,000
Closed -$248K
HPX.WS
1767
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
-16,602
Closed -$4K
IBER.WS
1768
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
-13,501
Closed -$1K
ABGI
1769
DELISTED
ABG Acquisition Corp. I
ABGI
-18,632
Closed -$185K
PAYA
1770
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
-13,988
Closed -$85K
CTAQ
1771
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
-20,385
Closed -$203K
SCOB
1772
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
-12,500
Closed -$124K
SCOBW
1773
DELISTED
ScION Tech Growth II Warrants
SCOBW
-11,998
Closed
BIOTW
1774
DELISTED
Biotech Acquisition Company Warrant
BIOTW
-18,731
Closed -$1K
FOXWW
1775
DELISTED
FoxWayne Enterprises Acquisition Corp. Warrant
FOXWW
-28,578
Closed -$3K

Similar funds

Prelude Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Prelude Capital Management held 1,961 positions worth $1.92B, down 31% from $2.79B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Prelude Capital Management withdrew a net $1.08B in Q4 2022, closing 669 positions and reducing 381 holdings. Its most notable exit was KKR Acquisition Holdings I Corp., an estimated $30.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in AVEO Pharmaceuticals, Inc. worth $7.55M.

  • Prelude Capital Management's largest Q4 2022 buy was AVEO Pharmaceuticals, Inc.: 504,972 shares worth $7.55M.
  • Prelude Capital Management added most to KE Holdings in Q4 2022, an estimated $13.6M increase.
  • Prelude Capital Management's biggest Q4 2022 reduction was Alphabet (Google) Class A, cutting an estimated $6.9M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. in Q4 2022, selling an estimated $30.7M.
  • Prelude Capital Management's ten largest holdings make up 25% of its $1.92B portfolio in Q4 2022.
  • Prelude Capital Management opened 419 new positions and closed 669 in Q4 2022.
  • Prelude Capital Management's portfolio value fell 31% quarter-over-quarter to $1.92B.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.